" class="no-js "lang="en-US"> Companies Archive - Page 67 of 145 - Medtech Alert
Wednesday, October 15, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Medical University of Vienna | Pharmtech Focus

Medical University of Vienna

View Company

 UnityPoint Health | Pharmtech Focus

UnityPoint Health

View Company

 Roche | Pharmtech Focus

Roche

View Company

 Creyon Bio | Pharmtech Focus

Creyon Bio

View Company

 TendoNova | Pharmtech Focus

TendoNova

View Company

 Vivo Capital | Pharmtech Focus

Vivo Capital

View Company

 InBrace | Pharmtech Focus

InBrace

View Company

 Geneos Therapeutics | Pharmtech Focus

Geneos Therapeutics

View Company

 ZERO | Pharmtech Focus

ZERO

View Company

 Tulane Cancer Center | Pharmtech Focus

Tulane Cancer Center

Load More Results